Market Study on Anti-VEGF: Close to Half of the Market Share Accounted for by Vascular Endothelial Growth Factor-A Inhibitors

Publish Date: Apr 2023

Report Code: PMR2411A

Publisher: Persistence Market Research

Single User License: $4900

Explore Our Services

Already a member? Login here.

Report Highlights

Anti-VEGF Market: Scope of the Report

The latest publication by Persistence Market Research on the global anti-VEGF market evaluates the opportunities and current market landscape and provides detailed analysis, and updates about corresponding sections affecting the market. The study offers detailed insights on current market dynamics, which include the drivers, restraints, trends, and opportunities in the market. The principal aim of the market study is to present exclusive information about how the market will perform during the forecast period of 2023 to 2033.

Important indicators for the successful growth of the market are presented in this comprehensive report, which includes a Year-on-Year (Y-o-Y) growth analysis of the market, and compounded annual growth rate (CAGR), which are described exhaustively in Persistence Market Research's study. This research study can support readers to know the demand for anti-VEGF products and the quantitative development opportunities during the study period.

The research is beneficial for shareholders in the landscape, including investors, manufacturers, service providers, distributors, and suppliers, and can help them in developing suitable business strategies to flourish in the anti-VEGF market. Shareholders in the anti-VEGF market, industry experts, investors, researchers, and reporters, as well as business enthusiasts can leverage insights and information presented in this Persistence Market Research study.

Market statistics, as well as information linked to the macro- as well as micro-economic variables affecting the business scenario in the anti-VEGF market, are also included in the current study. Depending on potential developments in the market, substantive insights are also encountered in this report. Additionally, by the data submitted in this report, minor companies and new entrants in the industry can be aided in making suitable company choices to achieve traction in the market.

Key Market Segments

Persistence Market Research’s study on the anti-VEGF market offers information divided into five important segments - drug, type, disease indication, distribution channel, and region. This report offers comprehensive data and information about the important market dynamics and growth parameters associated with these categories.

Drug

  • Small Molecules
  • Pazopanib
  • Sunitinib
  • Sorafenib
  • Regorafenib
  • Cabozantinib
  • Lenvatinib
  • Ponatinib
  • Cabozantinib
  • Axitinib
  • tivozanib
  • Vandetanib
  • Anlotinib
  • Apatinib
  • Fruquintinib
  • Surufatinib
  • Biologics
  • Bevacizumab
  • Aflibercept
  • Ramucirumab

Type

  • VEGF A Inhibitors
  • VEGF B Inhibitors
  • VEGF C Inhibitors
  • Placenta Growth Factor Inhibitors

Disease Indication

  • Oncology
  • Non-Small Cell Lung Cancer
  • Renal Cell Carcinoma
  • Colorectal Cancer
  • Hepatocellular Carcinoma
  • Cervical Cancer
  • Others
  • Hematology Disorders
  • Ophthalmology Disorders
  • Wet Age-Related Macular Degeneration (AMD)
  • Diabetic Retinopathy
  • Others

Distribution Channel

  • Hospitals
  • Specialty Clinics
  • Mail Order Pharmacies

Region

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa (MEA)

Key Questions Answered in Report

  • Which regions will continue to remain the most profitable markets for anti-VEGF over the coming years?
  • How will changing trends influence the market?
  • How has the COVID-19 crisis influenced market growth?
  • How can market players capture the low-hanging opportunities in developed regions?
  • What are the strategies of stakeholders in the market to shape their position in this landscape?
  • What are the restraining factors that investors need to be aware of and might tackle while investing in the market?
  • What are the developmental trends that will influence the market?
  • How can companies in the anti-VEGF market avail themselves the growth opportunities in developed and emerging sectors?

Report Synopsis

Report Metrics Details
Base year considered 2023
Forecast period considered 2023-2033
Units considered $ Million
Segments covered By Drug Class, By Types, By Disease Indication, By Distribution Channel, By Region
Industry covered Healthcare
Countries covered North America, Latin America, Europe, South Asia, East Asia, Oceania, Middle East and Africa
Companies studied
  • Pfizer Inc.
  • Exelixis Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi SA
  • Amgen Inc.
  • Eisai Co. Ltd.
  • F. Hoffmann-La Roche Ltd.
  • Eli Lilly and Company
  • Amneal Pharmaceuticals Inc.
  • Jiangsu Hengrui Pharmaceuticals Co. Ltd.
  • Takeda Pharmaceutical Co. Ltd.
  • Sino Biopharma
  • HUTCHMED

Research Methodology

In Persistence Market Research’s study, a unique research methodology is utilized to conduct extensive research on the growth of the anti-VEGF market, and reach conclusions on the future growth parameters of the market. This research methodology is a combination of primary and secondary research, which helps analysts to ensure the accuracy and reliability of the conclusions.

Secondary resources referred to by analysts during the production of the market study include statistics from governmental organizations, trade journals, white papers, and internal and external proprietary databases. Analysts have interviewed senior managers, product portfolio managers, CEOs, VPs, marketing/product managers, and market intelligence managers, who contributed to the development of this report as a primary resource.

Comprehensive information acquired from primary and secondary resources acts as validation from companies in the market, and makes Persistence Market Research’s projections on the growth prospects of the anti-VEGF market are more accurate and reliable.

  • Table 1 : Global Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 2 : Global Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 3 : Global Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 4 : Global Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 5 : Global Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 6 : Global Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 7 : Global Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 8 : Global Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 9 : Global Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 10 : Global Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 11 : Global Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Region
  • Table 12 : Global Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Region
  • Table 13 : North America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 14 : North America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 15 : North America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 16 : North America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 17 : North America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 18 : North America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 19 : North America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 20 : North America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 21 : North America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 22 : North America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 23 : North America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 24 : North America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 25 : Latin America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 26 : Latin America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 27 : Latin America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 28 : Latin America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 29 : Latin America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 30 : Latin America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 31 : Latin America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 32 : Latin America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 33 : Latin America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 34 : Latin America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 35 : Latin America Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 36 : Latin America Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 37 : Europe Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 38 : Europe Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 39 : Europe Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 40 : Europe Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 41 : Europe Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 42 : Europe Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 43 : Europe Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 44 : Europe Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 45 : Europe Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 46 : Europe Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 47 : Europe Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 48 : Europe Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 49 : East Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 50 : East Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 51 : East Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 52 : East Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 53 : East Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 54 : East Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 55 : East Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 56 : East Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 57 : East Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 58 : East Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 59 : East Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 60 : East Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 61 : South Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 62 : South Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 63 : South Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 64 : South Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 65 : South Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 66 : South Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 67 : South Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 68 : South Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 69 : South Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 70 : South Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 71 : South Asia Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 72 : South Asia Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 73 : Oceania Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 74 : Oceania Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 75 : Oceania Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 76 : Oceania Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 77 : Oceania Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 78 : Oceania Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 79 : Oceania Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 80 : Oceania Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 81 : Oceania Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 82 : Oceania Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 83 : Oceania Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 84 : Oceania Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Table 85 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Country
  • Table 86 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Country
  • Table 87 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 88 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Drug Types
  • Table 89 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 90 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Drug Types
  • Table 91 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Types
  • Table 92 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Types
  • Table 93 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Disease Indication
  • Table 94 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Disease Indication
  • Table 95 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Analysis 2012-2022, By Distribution Channel
  • Table 96 : Middle East & Africa Anti-VEGF Market Value (US$ Mn) Forecast 2023-2033, By Distribution Channel
  • Figure 1 : Global Anti-VEGF Market Value, 2012-2022
  • Figure 2 : Global Anti-VEGF Market Value (US$ Mn) & Y-o-Y Growth (%), 2022–2032
  • Figure 3 : Global Anti-VEGF Market Absolute $ Opportunity, 2022–2032
  • Figure 4 : Global Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2032
  • Figure 5 : Global Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 6 : Global Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2032
  • Figure 7 : Global Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 8 : Global Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2032
  • Figure 9 : Global Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 10 : Global Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 11 : Global Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2032
  • Figure 12 : Global Anti-VEGF Market Share Analysis (%) by Region, 2022 & 2032
  • Figure 13 : Global Anti-VEGF Market Attractiveness Analysis, By Region, 2023-2033
  • Figure 14 : North America Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 15 : North America Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 16 : North America Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 17 : North America Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 18 : North America Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 19 : North America Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 20 : North America Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 21 : North America Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 22 : North America Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 23 : North America Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 24 : North America Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 25 : North America Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 26 : U.S. Market Value Proportion Analysis, 2022
  • Figure 27 : U.S. Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 28 : U.S. Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 29 : U.S. Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 30 : U.S. Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 31 : Canada Market Value Proportion Analysis, 2022
  • Figure 32 : Canada Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 33 : Canada Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 34 : Canada Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 35 : Canada Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 36 : Latin America Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 37 : Latin America Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 38 : Latin America Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 39 : Latin America Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 40 : Latin America Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 41 : Latin America Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 42 : Latin America Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 43 : Latin America Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 44 : Latin America Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 45 : Latin America Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 46 : Latin America Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 47 : Latin America Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 48 : Brazil Market Value Proportion Analysis, 2022
  • Figure 49 : Brazil Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 50 : Brazil Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 51 : Brazil Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 52 : Brazil Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 53 : Mexico Market Value Proportion Analysis, 2022
  • Figure 54 : Mexico Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 55 : Mexico Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 56 : Mexico Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 57 : Mexico Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 58 : Argentina Market Value Proportion Analysis, 2022
  • Figure 59 : Argentina Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 60 : Argentina Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 61 : Argentina Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 62 : Argentina Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 63 : Europe Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 64 : Europe Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 65 : Europe Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 66 : Europe Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 67 : Europe Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 68 : Europe Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 69 : Europe Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 70 : Europe Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 71 : Europe Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 72 : Europe Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 73 : Europe Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 74 : Europe Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 75 : Germany Market Value Proportion Analysis, 2022
  • Figure 76 : Germany Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 77 : Germany Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 78 : Germany Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 79 : Germany Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 80 : U.K. Market Value Proportion Analysis, 2022
  • Figure 81 : U.K. Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 82 : U.K. Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 83 : U.K. Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 84 : U.K. Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 85 : Italy Market Value Proportion Analysis, 2022
  • Figure 86 : Italy Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 87 : Italy Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 88 : Italy Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 89 : Italy Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 90 : France Market Value Proportion Analysis, 2022
  • Figure 91 : France Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 92 : France Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 93 : France Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 94 : France Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 95 : Spain Market Value Proportion Analysis, 2022
  • Figure 96 : Spain Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 97 : Spain Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 98 : Spain Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 99 : Spain Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 100 : Russia Market Value Proportion Analysis, 2022
  • Figure 101 : Russia Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 102 : Russia Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 103 : Russia Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 104 : Russia Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 105 : Nordic Countries Market Value Proportion Analysis, 2022
  • Figure 106 : Nordic Countries Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 107 : Nordic Countries Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 108 : Nordic Countries Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 109 : Nordic Countries Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 110 : BENULUX Market Value Proportion Analysis, 2022
  • Figure 111 : BENULUX Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 112 : BENULUX Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 113 : BENULUX Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 114 : BENULUX Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 115 : East Asia Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 116 : East Asia Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 117 : East Asia Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 118 : East Asia Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 119 : East Asia Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 120 : East Asia Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 121 : East Asia Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 122 : East Asia Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 123 : East Asia Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 124 : East Asia Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 125 : East Asia Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 126 : East Asia Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 127 : China Market Value Proportion Analysis, 2022
  • Figure 128 : China Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 129 : China Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 130 : China Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 131 : China Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 132 : Japan Market Value Proportion Analysis, 2022
  • Figure 133 : Japan Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 134 : Japan Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 135 : Japan Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 136 : Japan Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 137 : South Korea Market Value Proportion Analysis, 2022
  • Figure 138 : South Korea Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 139 : South Korea Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 140 : South Korea Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 141 : South Korea Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 142 : South Asia Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 143 : South Asia Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 144 : South Asia Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 145 : South Asia Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 146 : South Asia Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 147 : South Asia Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 148 : South Asia Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 149 : South Asia Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 150 : South Asia Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 151 : South Asia Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 152 : South Asia Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 153 : South Asia Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 154 : India Market Value Proportion Analysis, 2022
  • Figure 155 : India Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 156 : India Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 157 : India Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 158 : India Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 159 : Thailand Market Value Proportion Analysis, 2022
  • Figure 160 : Thailand Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 161 : Thailand Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 162 : Thailand Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 163 : Thailand Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 164 : Indonesia Market Value Proportion Analysis, 2022
  • Figure 165 : Indonesia Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 166 : Indonesia Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 167 : Indonesia Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 168 : Indonesia Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 169 : Malaysia Market Value Proportion Analysis, 2022
  • Figure 170 : Malaysia Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 171 : Malaysia Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 172 : Malaysia Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 173 : Malaysia Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 174 : Oceania Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 175 : Oceania Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 176 : Oceania Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 177 : Oceania Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 178 : Oceania Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 179 : Oceania Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 180 : Oceania Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 181 : Oceania Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 182 : Oceania Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 183 : Oceania Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 184 : Oceania Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 185 : Oceania Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 186 : Australia Market Value Proportion Analysis, 2022
  • Figure 187 : Australia Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 188 : Australia Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 189 : Australia Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 190 : Australia Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 191 : New Zealand Market Value Proportion Analysis, 2022
  • Figure 192 : New Zealand Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 193 : New Zealand Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 194 : New Zealand Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 195 : New Zealand Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 196 : Middle East & Africa Anti-VEGF Market Value Share, By Country (2023 E)
  • Figure 197 : Middle East & Africa Anti-VEGF Market Value Share, By Drug Type (2023 E)
  • Figure 198 : Middle East & Africa Anti-VEGF Market Value Share, By Types (2023 E)
  • Figure 199 : Middle East & Africa Anti-VEGF Market Value Share, By Disease Indication (2023 E)
  • Figure 200 : Middle East & Africa Anti-VEGF Market Value Share, By Distribution Channel (2023 E)
  • Figure 201 : Middle East & Africa Anti-VEGF Market Size (US$ Mn) Analysis, 2012-2022
  • Figure 202 : Middle East & Africa Anti-VEGF Market Size (US$ Mn) & Y-o-Y Growth (%), 2023-2033
  • Figure 203 : Middle East & Africa Anti-VEGF Market Attractiveness Analysis, By Drug Types, 2023-2033
  • Figure 204 : Middle East & Africa Anti-VEGF Market Attractiveness Analysis, By Types, 2023-2033
  • Figure 205 : Middle East & Africa Anti-VEGF Market Attractiveness Analysis, By Disease Indication, 2023-2033
  • Figure 206 : Middle East & Africa Anti-VEGF Market Attractiveness Analysis, By Distribution Channel, 2023-2033
  • Figure 207 : Middle East & Africa Anti-VEGF Market Attractiveness Analysis, By Country, 2023-2033
  • Figure 208 : GCC Countries Market Value Proportion Analysis, 2022
  • Figure 209 : GCC Countries Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 210 : GCC Countries Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 211 : GCC Countries Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 212 : GCC Countries Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 213 : Turkiye Market Value Proportion Analysis, 2022
  • Figure 214 : Turkiye Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 215 : Turkiye Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 216 : Turkiye Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 217 : Turkiye Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 218 : North Africa Market Value Proportion Analysis, 2022
  • Figure 219 : North Africa Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 220 : North Africa Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 221 : North Africa Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 222 : North Africa Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033
  • Figure 223 : South Africa Market Value Proportion Analysis, 2022
  • Figure 224 : South Africa Anti-VEGF Market Share Analysis (%) by Drug Types, 2022 & 2033
  • Figure 225 : South Africa Anti-VEGF Market Share Analysis (%) by Types, 2022 & 2033
  • Figure 226 : South Africa Anti-VEGF Market Share Analysis (%) by Disease Indication, 2022 & 2033
  • Figure 227 : South Africa Anti-VEGF Market Share Analysis (%) by Distribution Channel, 2022 & 2033

Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.

To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organization of all sizes.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Market Study on Anti-VEGF: Close to Half of the Market Share Accounted for by Vascular Endothelial Growth Factor-A...